- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
8
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
8 companies
AstraZeneca
Market Cap: UK£200.7b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£129.40
7D
3.6%
1Y
16.0%
Gilead Sciences
Market Cap: US$162.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$134.32
7D
3.1%
1Y
17.6%
Chugai Pharmaceutical
Market Cap: JP¥11.5t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,999.00
7D
-5.4%
1Y
-5.1%
Orion Oyj
Market Cap: €11.4b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€80.75
7D
5.5%
1Y
14.5%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥52.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥116.35
7D
-12.5%
1Y
15.6%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€59.65
7D
9.0%
1Y
7.0%
Xiamen Amoytop Biotech
Market Cap: CN¥23.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥57.59
7D
-4.3%
1Y
-25.6%
PharmaResearch
Market Cap: ₩3.9t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩375,500.00
7D
10.0%
1Y
-33.8%